365mc Rises as a Global Brand! Raziel Visit & World Knowledge Forum Invitation ✨
Hello,
This is Lipo Maniac 365mc.
365mc is now moving beyond Asia, stepping into the global stage alongside the world’s leading figures in biotechnology.
This past July, following the signing of a Memorandum of Understanding (MOU) in the United States, Mr. Philippe, Chairman of global biotech company Raziel Therapeutics, Mr. Alon, CEO, and Mr. Bruno Cohen, Chairman of the Galien Foundation—which oversees the “Nobel Prize of the pharmaceutical industry”—personally visited Korea. Their visit included Seoul 365mc Hospital, our headquarters and flagship branch, as well as the LAMS Hospital, the home of the LAMS procedure.
Far from a formal courtesy visit, this was a meaningful occasion where the Raziel leadership actively came to Korea to strengthen strategic cooperation with 365mc. On site, Chairman Philippe and 365mc CEO Mr. Nam Chul Kim held in-depth discussions on mid- to long-term collaboration, 365mc’s overseas expansion strategy, and global projects combining Raziel’s new drug development with 365mc’s LAMS procedure.
The Raziel delegation expressed their strong impression of 365mc’s advanced obesity-treatment infrastructure and differentiated system, and conveyed high expectations for the synergies to come.
Later, Chairman Philippe Raziel was invited as a keynote speaker at the “2025 World Knowledge Forum K-Bio Night,” held at the Dynasty Hall of The Shilla Seoul. Representing global leaders in the pharmaceutical and biotechnology industry, he delivered a speech on growth strategies for the advancement of K-Bio.
The “World Knowledge Forum” is the largest global business, political, and scientific forum in Asia, attended by heads of state, Nobel laureates, and CEOs of leading global enterprises. 365mc was also formally invited to this prestigious gathering, with CEO Nam Chul Kim attending the dinner session.
This was more than a simple invitation—it was a symbolic moment that highlighted 365mc’s rising international stature as a brand recognized alongside global economic and scientific leaders. At the forum, Chairman Philippe Raziel addressed major issues in the global biotechnology industry and specifically cited the MOU between Raziel Therapeutics and 365mc as a key example.
He stated, “365mc’s bold approach—challenging the global stage with its expertise in fat treatment alone—has brought a refreshing shock to the conventional framework of biotech therapies. The collaboration between our two companies will serve as a new bridge between obesity treatment and innovative drug development.” His remarks drew significant attention.
The “World Knowledge Forum” is the largest global business, political, and scientific forum in Asia, attended by heads of state, Nobel laureates, and CEOs of leading global enterprises. 365mc was also formally invited to this prestigious gathering, with CEO Nam Chul Kim attending the dinner session.
This was more than a simple invitation—it was a symbolic moment that highlighted 365mc’s rising international stature as a brand recognized alongside global economic and scientific leaders. At the forum, Chairman Philippe Raziel addressed major issues in the global biotechnology industry and specifically cited the MOU between Raziel Therapeutics and 365mc as a key example.
He stated, “365mc’s bold approach—challenging the global stage with its expertise in fat treatment alone—has brought a refreshing shock to the conventional framework of biotech therapies. The collaboration between our two companies will serve as a new bridge between obesity treatment and innovative drug development.” His remarks drew significant attention.
In this way, 365mc’s vision and expertise are spreading worldwide ✈
Looking ahead, 365mc will continue to expand its global presence—not only through medical technology exchange but also by leading the healthcare market with strategic partnerships
This was more than a simple invitation—it was a symbolic moment that highlighted 365mc’s rising international stature as a brand recognized alongside global economic and scientific leaders. At the forum, Chairman Philippe Raziel addressed major issues in the global biotechnology industry and specifically cited the MOU between Raziel Therapeutics and 365mc as a key example.
He stated, “365mc’s bold approach—challenging the global stage with its expertise in fat treatment alone—has brought a refreshing shock to the conventional framework of biotech therapies. The collaboration between our two companies will serve as a new bridge between obesity treatment and innovative drug development.” His remarks drew significant attention.
Thank you.
